Gabapentin prodrug sustained release oral dosage forms

Details Gabapentin prodrug sustained release oral dosage forms Gabapentin prodrug sustained release oral dosage forms

A - Human Necessities

61

K

A61K 31/197 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2584338

Sustained release oral dosage forms of a gabapentin prodrug, 1 {[(a- isobutanoyloxyethoxy)carbonyl]aminomethyl} 1 cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective.

L'invention concerne des formes posologiques orales à libération prolongée d'un promédicament du nom de gabapentine, l'acide 1-{[(.alpha.-isobutanoyloxyéthoxy)carbonyl]aminométhyl}-1-cyclohexane-acétique. Ces formes posologiques sont utiles pour traiter ou prévenir des maladies et des troubles pour lesquels la gabapentine est efficace sur le plan thérapeutique.

Affiliated with

Also associated with

Rating

Gabapentin prodrug sustained release oral dosage forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gabapentin prodrug sustained release oral dosage forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gabapentin prodrug sustained release oral dosage forms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1553567